lenalidomide has been researched along with Dermatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bessis, D; Cezar, R; Corbeau, P; Poujade, L; Samaran, Q; Sarrabay, G; Tran, TA | 1 |
| Balin, SJ; Kurtin, PJ; Letendre, L; Pittelkow, MR; Wetter, DA | 1 |
2 other study(ies) available for lenalidomide and Dermatitis
| Article | Year |
|---|---|
Lenalidomide for treatment of refractory aphthosis and neutrophilic pustulosis in familial pyrin-associated autoinflammation with neutrophilic dermatosis.
Topics: Dermatitis; Humans; Lenalidomide; Neutrophils; Pyoderma Gangrenosum; Pyrin; Stomatitis, Aphthous | 2023 |
Myelodysplastic syndrome presenting as generalized granulomatous dermatitis.
Topics: Aged; Antineoplastic Agents; Biopsy; Blood Cell Count; Dermatitis; Disease Progression; Granuloma; Humans; Lenalidomide; Male; Myelodysplastic Syndromes; Pruritus; Thalidomide; Time Factors | 2011 |